
Rare Kidney Diseases Global Market Report 2023 Including: 1) By Target Indication: IgA Nephropathy; Lupus Nephritis; Focal Segmental Glomerular Sclerosis; Membranous Nephropathy; C3 Glomerulopathy 2) By Type of Molecule: Small Molecules; Biologics 3) By
Description
Rare Kidney Diseases Global Market Report 2023
Including: 1) By Target Indication: IgA Nephropathy; Lupus Nephritis; Focal Segmental Glomerular Sclerosis; Membranous Nephropathy; C3 Glomerulopathy2) By Type of Molecule:Small Molecules; Biologics3) By Route of administration: Oral; Intravenous; SubcutaneousCovering: Merck & Co. Inc.; Novartis AG; Sanofi S.A; AstraZeneca plc; GlaxoSmithKline plc
Rare Kidney Diseases Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on rare kidney diseases market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for rare kidney diseases? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rare kidney diseases market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Target Indication: IgA Nephropathy; Lupus Nephritis; Focal Segmental Glomerular Sclerosis; Membranous Nephropathy; C3 Glomerulopathy; Other Target Indications
2) By Type of Molecule:
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Rare Kidney Diseases Market Characteristics
- 3. Rare Kidney Diseases Market Trends And Strategies
- 4. Rare Kidney Diseases Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On Online Therapy Services Market
- 4.2. Ukraine-Russia War Impact On Online Therapy Services Market
- 4.3. COVID-19 Impact On Online Therapy Services Market
- 5.1. Global Rare Kidney Diseases Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
- 5.2. Global Rare Kidney Diseases Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
- 5.3. Global Rare Kidney Diseases Market Drivers and Restraints
- 5.3.1. Drivers Of The Market
- 5.3.2. Restraints Of The Market
- 6. Rare Kidney Diseases Market Segmentation
- 6.1. Global Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- IgA Nephropathy
- Lupus Nephritis
- Focal Segmental Glomerular Sclerosis
- Membranous Nephropathy
- C3 Glomerulopathy
- Other Target Indications
- 6.2. Global Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Small Molecules
- Biologics
- 6.3. Global Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Oral
- Intravenous
- Subcutaneous
- Other Routes of Administration
- 7. Rare Kidney Diseases Market Regional And Country Analysis
- 7.1. Global Rare Kidney Diseases Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 7.2. Global Rare Kidney Diseases Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8. Asia-Pacific Rare Kidney Diseases Market
- 8.1. Asia-Pacific Rare Kidney Diseases Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8.3. Asia-Pacific Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8.4. Asia-Pacific Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 9. China Rare Kidney Diseases Market
- 9.1. China Rare Kidney Diseases Market Overview
- 9.2. China Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 9.3. China Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 9.4. China Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 10. India Rare Kidney Diseases Market
- 10.1. India Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 10.2. India Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 10.3. India Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11. Japan Rare Kidney Diseases Market
- 11.1. Japan Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11.2. Japan Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11.3. Japan Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12. Australia Rare Kidney Diseases Market
- 12.1. Australia Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12.2. Australia Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12.3. Australia Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13. Indonesia Rare Kidney Diseases Market
- 13.1. Indonesia Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13.2. Indonesia Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13.3. Indonesia Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14. South Korea Rare Kidney Diseases Market
- 14.1. South Korea Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14.2. South Korea Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14.3. South Korea Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15. Western Europe Rare Kidney Diseases Market
- 15.1. Western Europe Rare Kidney Diseases Market Overview
- 15.2. Western Europe Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15.3. Western Europe Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15.4. Western Europe Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16. UK Rare Kidney Diseases Market
- 16.1. UK Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16.2. UK Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16.3. UK Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17. Germany Rare Kidney Diseases Market
- 17.1. Germany Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17.2. Germany Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17.3. Germany Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18. France Rare Kidney Diseases Market
- 18.1. France Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18.2. France Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18.3. France Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19. Italy Rare Kidney Diseases Market
- 19.1. Italy Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19.2. Italy Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19.3. Italy Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20. Spain Rare Kidney Diseases Market
- 20.1. Spain Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20.2. Spain Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20.3. Spain Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21. Eastern Europe Rare Kidney Diseases Market
- 21.1. Eastern Europe Rare Kidney Diseases Market Overview
- 21.2. Eastern Europe Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21.3. Eastern Europe Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21.4. Eastern Europe Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22. Russia Rare Kidney Diseases Market
- 22.1. Russia Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22.2. Russia Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22.3. Russia Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23. North America Rare Kidney Diseases Market
- 23.1. North America Rare Kidney Diseases Market Overview
- 23.2. North America Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23.3. North America Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23.4. North America Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24. USA Rare Kidney Diseases Market
- 24.1. USA Rare Kidney Diseases Market Overview
- 24.2. USA Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24.3. USA Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24.4. USA Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25. Canada Rare Kidney Diseases Market
- 25.1. Canada Rare Kidney Diseases Market Overview
- 25.2. Canada Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25.3. Canada Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25.4. Canada Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26. South America Rare Kidney Diseases Market
- 26.1. South America Rare Kidney Diseases Market Overview
- 26.2. South America Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26.3. South America Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26.4. South America Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27. Brazil Rare Kidney Diseases Market
- 27.1. Brazil Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27.2. Brazil Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27.3. Brazil Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 28. Middle East Rare Kidney Diseases Market
- 28.1. Middle East Rare Kidney Diseases Market Overview
- 28.2. Middle East Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 28.3. Middle East Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 28.4. Middle East Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 29. Africa Rare Kidney Diseases Market
- 29.1. Africa Rare Kidney Diseases Market Overview
- 29.2. Africa Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 29.3. Africa Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 29.4. Africa Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 30. Rare Kidney Diseases Market Competitive Landscape And Company Profiles
- 30.1. Rare Kidney Diseases Market Competitive Landscape
- 30.2. Rare Kidney Diseases Market Company Profiles
- 30.2.1. Merck & Co. Inc.
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. Novartis AG
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. Sanofi S.A
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. AstraZeneca plc
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. GlaxoSmithKline plc
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 31. Rare Kidney Diseases Market Other Major And Innovative Companies
- 31.1. Otsuka Pharmaceutical Co Ltd.
- 31.2. Alexion Pharmaceuticals Inc.
- 31.3. Horizon Therapeutics plc.
- 31.4. Recordati S.p.A.
- 31.5. Proteostasis Therapeutics
- 31.6. Amicus Therapeutics Inc.
- 31.7. Akebia Therapeutics Inc.
- 31.8. Travere Therapeutics
- 31.9. FibroGen Inc.
- 31.10. Aurinia Pharmaceuticals Inc.
- 31.11. Calliditas Therapeutics AB
- 31.12. Apellis Pharmaceuticals Inc.
- 31.13. Protalix Biotherapeutics Inc.
- 31.14. ChemoCentryx Inc.
- 31.15. Omeros Corporation
- 32. Global Rare Kidney Diseases Market Competitive Benchmarking
- 33. Global Rare Kidney Diseases Market Competitive Dashboard
- 34. Key Mergers And Acquisitions In The Rare Kidney Diseases Market
- 35. Rare Kidney Diseases Market Future Outlook and Potential Analysis
- 35.1 Rare Kidney Diseases Market In 2027 - Countries Offering Most New Opportunities
- 35.2 Rare Kidney Diseases Market In 2027 - Segments Offering Most New Opportunities
- 35.3 Rare Kidney Diseases Market In 2027 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.